Hookipa Pharma Executes 1-for-10 Reverse Stock Split for Nasdaq Compliance

Monday, 8 July 2024, 12:28

Hookipa Pharma (HOOK) has announced a 1-for-10 reverse stock split to meet Nasdaq listing requirements. The company aims to ensure compliance and maintain its market presence. Shareholders will experience a consolidation of their shares, impacting the stock's trading value.

LivaRava Finance Meta Image — Hookipa Pharma Executes 1-for-10 Reverse Stock Split for Nasdaq Compliance

Hookipa Pharma Announces 1-for-10 Reverse Stock Split

Hookipa Pharma (ticker: HOOK) has revealed plans for a 1-for-10 reverse stock split to comply with Nasdaq requirements.

Objective: Regaining Nasdaq Compliance

Timing: July 9, 2024
Investors holding Hookipa Pharma shares will see a consolidation ratio of 1-for-10.
Instituting this stock split positions Hookipa Pharma to meet listing standards and safeguard its market position.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.